BICELTIS 400MG
DESCRIPTION :
Biceltis is a group of medicines which belongs to anti neoplastic medication. Biceltis is a chemotherapy drug. It is recommended that Biceltis be administered under the guidance of a qualified physician experienced in the use of cancer chemotherapeutic agents.
USES
The injection Biceltis is used alone or combination with other medicine for the treatment in patients who suffering from metastatic breast cancer.
The drug also indicated with combination of other medicine for the treatment of certain types of stomach or esophagus cancer in some persons.
The drug also indicated with combination of other medicine for the treatment of certain types of stomach or esophagus cancer in some persons.
WORK AS
Different type of breast cancer cells has a higher than normal level of a protein called HER2 (human epidermal growth factor receptor 2) on their surface. These HER2 receptors get signals which stimulate the tumor cells to develop and reproduce. But breast cancer cells with too many HER2 receptors can Choice too many growth signals and so start developing and proliferating too much and too fast.
Biceltis acts by adhere itself to the HER2 receptors on the surface of breast cancer cells and stopping them from collecting growth signals. By stopping the signals, Biceltis can slow or inhibit the growth of the breast cancer and the drug is an immune targeted therapy. In addition to inhibiting HER2 receptors, Trastuzumab can also help to fight against breast cancer by attentive the immune system to damage the cancer cells onto which it is attached.
Biceltis acts by adhere itself to the HER2 receptors on the surface of breast cancer cells and stopping them from collecting growth signals. By stopping the signals, Biceltis can slow or inhibit the growth of the breast cancer and the drug is an immune targeted therapy. In addition to inhibiting HER2 receptors, Trastuzumab can also help to fight against breast cancer by attentive the immune system to damage the cancer cells onto which it is attached.
DRUG INTERACTION
In some phenomenal condition, patient should get anthracycline, in that situation patient’s cardiac function should be checked carefully with regular intervals.
Do not take anthracycline treatment for 7 months after stopping the Biceltis treatment.
Biceltis interaction with anthracycline after ending of Biceltis treatment may have a chance of getting cardiac problem. This side effects occur because of Trastuzumab great disaster period is depends on population PK analysis.
Do not take anthracycline treatment for 7 months after stopping the Biceltis treatment.
Biceltis interaction with anthracycline after ending of Biceltis treatment may have a chance of getting cardiac problem. This side effects occur because of Trastuzumab great disaster period is depends on population PK analysis.
CONTRAINDICATION
Probably no contraindicated occurs.
The patients are contraindicated to the component present in the Biceltis, Hence Hypersensitivity reactions are occurring.
The patients are contraindicated to the component present in the Biceltis, Hence Hypersensitivity reactions are occurring.
STORAGE
Store the drug at 2℃ to 8℃ (refrigerator temperature) Protected the vial away from heat & light Stored at 2℃ to 8℃ for 28 days after reconstitution Stored Biceltis diluted bag at 2℃ to 8℃ for 24 hours.
MISSED DOSE
The drug Missing doses can decrease their usefulness and raises the probability of developing drug resistance, that makes this drug lose their potency. For best results, it is important to accept each scheduled dose of Trastuzumab medication as instructed. If you miss a dose, leave the missed dose and continue with your regular dosing schedule. Do not have two doses to make up for a missed one. If you are not sure about what to do after missing a dose, the take advice with doctor or pharmacist.
For More Information :
Call us : +91-9987711567
Mail to : applepharmaceutical@gmail.com
No comments:
Post a Comment